Predicting Non-Alcoholic Fatty Liver Disease for Adults Using Practical Clinical Measures: Evidence from the Multi-ethnic Study of Atherosclerosis

• Published in: Journal of general internal medicine : JGIM 2021-09, Vol.36 (9), p.2648-2655
• Main Authors: Rodriguez, Luis A., Shiboski, Stephen C., Bradshaw, Patrick T., Fernandez, Alicia, Herrington, David, Ding, Jingzhong, Bradley, Ryan D., Kanaya, Alka M.
• Format: Article
• Language: English
• Subjects: Adults; Arteriosclerosis; Atherosclerosis; Body mass; Body mass index; Body measurements; Body size; Computed tomography; Demographics; Demography; Derivation; Diabetes mellitus (non-insulin dependent); Ethnic factors; Fatty liver; Internal Medicine; Liver; Liver diseases; Medical imaging; Medicine; Medicine & Public Health; Minority & ethnic groups; Original Research; Risk analysis; Risk factors; Steatosis; Triglycerides; γ-Glutamyltransferase
• ISSN: 0884-8734; 1525-1497
• DOI: 10.1007/s11606-020-06426-5

Background Many adults have risk factors for non-alcoholic fatty liver disease (NAFLD). Screening all adults with risk factors for NAFLD using imaging is not feasible. Objective To develop a practical scoring tool for predicting NAFLD using participant demographics, medical history, anthropometrics, and lab values. Design Cross-sectional. Participants Data came from 6194 white, African American, Hispanic, and Chinese American participants from the Multi-Ethnic Study of Atherosclerosis cohort, ages 45–85 years. Main Measures NAFLD was identified by liver computed tomography (≤ 40 Hounsfield units indicating > 30% hepatic steatosis) and data on 14 predictors was assessed for predicting NAFLD. Random forest variable importance was used to identify the minimum subset of variables required to achieve the highest predictive power. This subset was used to derive ( n = 4132) and validate ( n = 2063) a logistic regression–based score (NAFLD-MESA Index). A second NAFLD-Clinical Index excluding laboratory predictors was also developed. Key Results NAFLD prevalence was 6.2%. The model included eight predictors: age, sex, race/ethnicity, type 2 diabetes, smoking history, body mass index, gamma-glutamyltransferase (GGT), and triglycerides (TG). The NAFLD-Clinical Index model excluded GGT and TG. In the NAFLD-MESA model, the derivation set achieved an AUC NAFLD-MESA = 0.83 (95% CI, 0.81 to 0.86), and the validation set an AUC NAFLD-MESA = 0.80 (0.77 to 0.84). The NAFLD-Clinical Index model was AUC Clinical = 0.78 [0.75 to 0.81] in the derivation set and AUC Clinical = 0.76 [0.72 to 0.80] in the validation set ( p Bonferroni-adjusted < 0.01). Conclusions The two models are simple but highly predictive tools that can aid clinicians to identify individuals at high NAFLD risk who could benefit from imaging.